Clinical trial · Observational
The Role of Diet and Lifestyle in Breast Cancer Survival
The Role of Diet, Complementary Treatment and Lifestyle in Breast Cancer Progression and Survival
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Diet has been found to influence hormone production and metabolism which in turn could affect the incidence of hormone related cancers. Consumption of soy-containing foods, known to be rich in phytoestrogens, is thought to be one of the chemoprotective factors against breast cancer in Asian populations. Phytoestrogens have a wide range of metabolic effects and may have a role in effecting breast cancer risk. Although there is mounting evidence of the positive influence of phytoestrogens on breast cancer risk, very little research has been carried out in humans as to the effects of phytoestrogens on breast cancer recurrence and survival. The DietCompLyf study aims to explore this effect by carrying out an observational study in 3,000 breast cancer women in the UK. The effects of diet, lifestyle practices and use of complementary treatments will also be investigated. Participants are recruited 9-15 months post-diagnosis and followed up for 5 years. Questionnaires as well as blood and urine samples are collected annually.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- To assess the association between phytoestrogens and relapse free survival
- timeFrame
- Up to 5 years post-diagnosis
Secondary outcomes (2)
- measure
- To assess the association between phytoestrogens and event free survival
- timeFrame
- Up to 5 years post-diagnosis
- measure
- To assess the association between phytoestrogens and recurrence free survival
- timeFrame
- Up to 5 years post-diagnosis
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Women with histologically confirmed invasive primary breast cancer grades I to III. * age up to and including 75 years old Exclusion Criteria: * Previous cancer with the exception of basal cell carcinoma * Concomitant primary cancer * Bilateral cancer of the breast * Psychological problems * Cognitive impairment * Poor understanding of English
References
Publications (0)
Data not yet available